57 related articles for article (PubMed ID: 3957492)
1. Prevention of bronchial hyperreactivity in atopic asthmatics during the period of maximal allergenic risk: a six-month study.
Dal Negro RW; Turco P; Zoccatelli O; Trevisan F; Pomari C
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):100-3. PubMed ID: 3957492
[TBL] [Abstract][Full Text] [Related]
2. The effect of food on the bronchial response in adult asthmatic patients, and the protective role of ketotifen.
Furlan J; Suskovic S; Rus A
Allergol Immunopathol (Madr); 1987; 15(2):73-81. PubMed ID: 3618443
[TBL] [Abstract][Full Text] [Related]
3. The orally administered anti-allergic agent, ketotifen; efficacy in atopic and non-atopic bronchial asthma.
Carrasco E; Galleguillos F; Bernath Z
Allergol Immunopathol (Madr); 1981; 9(4):335-42. PubMed ID: 7030036
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the inhibitory effects of ketotifen and disodium cromoglycate on bronchial responses to house dust, with special reference to the late asthmatic response.
Adachi M; Kobayashi H; Aoki N; Iijima M; Kokubu F; Furuya A; Takahashi T
Pharmatherapeutica; 1984; 4(1):36-42. PubMed ID: 6438649
[TBL] [Abstract][Full Text] [Related]
5. Long term trial of ketotifen in bronchial asthma.
Podleski WK; Zelenak TM; Schmidt JL
Ann Allergy; 1984 Jun; 52(6):406-10. PubMed ID: 6428279
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological rehabilitation of the asthmatic child.
Debelić M
Allergol Immunopathol (Madr); 1981; Suppl 9():99-102. PubMed ID: 6819777
[TBL] [Abstract][Full Text] [Related]
7. Bronchial asthma induced by mediators produced in vitro by sensitized lymphomonocytes. Protective effect of ketotifen.
Lech B; Girard JP
Allergol Immunopathol (Madr); 1987; 15(4):191-4. PubMed ID: 3318348
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of ketotifen in the prophylactic treatment of bronchial asthma in children.
Naspitz CK; Freire CA
Allergol Immunopathol (Madr); 1988; 16(1):27-31. PubMed ID: 3381712
[TBL] [Abstract][Full Text] [Related]
9. [Role of ketotifen in the immunotherapy of atopic asthmatics].
Haddad G; Pacaud D; Papeix P; Tran Q; Vincent J; Steeg LF
Allerg Immunol (Paris); 1986 May; 18(5):13-6. PubMed ID: 3453715
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of ketotifen in exercise-induced bronchospasm.
Moreno MV; Fernández M; de la Cuesta CG; Oehling A
Allergol Immunopathol (Madr); 1988; 16(2):91-4. PubMed ID: 3394595
[TBL] [Abstract][Full Text] [Related]
11. [Bronchial hypersensitivity and development of bronchial asthma in children with atopic dermatitis].
Kayahara M; Murakami G; Adachi Y; Matsuno M; Adachi Y; Onoue Y; Iwaya M; Takayanagi M; Ikarashi T
Arerugi; 1994 Jul; 43(7):759-65. PubMed ID: 7980015
[TBL] [Abstract][Full Text] [Related]
12. [Long-term treatment of bronchial asthma with ketotifen. Relation to bronchial hyperirritability].
Mathov E; Grinstein M; Greiding L; Salmun N; Núñez J; Cortegiani D; Trento H; Capolungo O; Simkin G
Alergia; 1983 Jan; 30(1):13-26. PubMed ID: 6346930
[No Abstract] [Full Text] [Related]
13. Clinical studies on the protective effects of Ketotifen and Intal in atopic asthmatic patients.
Románski B; Pawlik-Miskiewicz K; Wilewska-Klubo T
Allergol Immunopathol (Madr); 1983; 11(1):34-9. PubMed ID: 6407291
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of sensitivity and specifity of two bronchial provocation tests with methacholine and hypertonic saline in bronchial hyperreactivity evaluation in asthmatics].
Piotrowska T; Siergiejko G; Siergiejko Z
Pol Merkur Lekarski; 2007 Feb; 22(128):126-9. PubMed ID: 17598657
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of exercise test and bronchial reversibility test as tools for asthma diagnosis in patients with normal spirometry].
Kuziemski K; Jassem E; Słomiński JM; Ruczyński J
Przegl Lek; 2006; 63(12):1269-72. PubMed ID: 17642137
[TBL] [Abstract][Full Text] [Related]
16. Bronchial hyper-responsiveness predicts the development of mild clinical asthma within 2 yr in school children with hay-fever.
Ferdousi HA; Zetterström O; Dreborg S
Pediatr Allergy Immunol; 2005 Sep; 16(6):478-86. PubMed ID: 16176394
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of early and late asthmatic responses to allergen challenge in a large group of asthmatics.
Dente FL; Bacci E; di Franco A; Giannini D; Conti I; Macchioni P; Scuotri L; Taccola M; Vagaggini B; Paggiaro PL
Respir Med; 2000 May; 94(5):441-7. PubMed ID: 10868707
[TBL] [Abstract][Full Text] [Related]
18. Ketotifen and bronchial hyperreactivity in asthmatic patients.
Girard JP
Clin Allergy; 1981 Sep; 11(5):449-52. PubMed ID: 7318164
[No Abstract] [Full Text] [Related]
19. Relationship between exposure to domestic allergens and bronchial hyperresponsiveness in non-sensitised, atopic asthmatic subjects.
Langley SJ; Goldthorpe S; Craven M; Woodcock A; Custovic A
Thorax; 2005 Jan; 60(1):17-21. PubMed ID: 15618577
[TBL] [Abstract][Full Text] [Related]
20. Inflammation and functional outcome in diisocyanate-induced asthma after cessation of exposure.
Piirilä PL; Meuronen A; Majuri ML; Luukkonen R; Mäntylä T; Wolff HJ; Nordman H; Alenius H; Laitinen A
Allergy; 2008 May; 63(5):583-91. PubMed ID: 18394133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
